Inauguration of Training facilities and launch of Post Graduate Diploma in Advanced Pharmacy (PGDAP)

MUMBAI, MAHARASHTRA, INDIA, August 4, 2013 /EINPresswire.com/ -- “Current pharmaceutical education system generates candidates that don’t have relevant skills for different jobs in industry. Apart from that knowledge about systems, software and documentation is lagging in students. As conventional courses fail to fulfil trained manpower requirement of pharmaceutical industry, there is need for devising courses that will bridge gaps between industrial and academic environment. InClinition’s PG Diploma in Advanced Pharmacy will provide best fit of students passing out from academia into industry”, said Dr. Ravindra B. Palkar, Vice-President, Technical, DK Pharmachem Pvt. Ltd. He was speaking at time of inauguration function of course and training centre of InClinition at Dombivli, Mumbai.

“Current course devised by our company has 10 different modules that cover entire spectrum of Pharma industry, right from regulatory, IPR to clinical research. This course is well equipped with virtual learning environment (VLE) facilities, android application along with regular classroom training to students. Apart from these, students will get e-newsletter fortnightly, experts group discussion forum membership, updates of scientific meeting and conferences including coverage on regulatory amendments. As intake of course in only 15, we can focus on development and placement of our students. We are also planning to launch distance learning batch of this course by end of August 2013”, said Mr. Avinash Deodhar, Director, InClinition.

The course will be conducted on weekend at training centre of InClinition in Dombivli, Mumbai. InClinition, pharmaceutical and clinical organisation with expertise in pharmaceutical and clinical research and has been involved e-learning courses on clinical research, medical writing, medical tourism, regulatory affairs. Please visit: www.inclinition.com

Avinash Deodhar
InClinition
8898904115
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.